Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning
Open Access
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyJAMA Neurology, 2024
- The tryptophan metabolism, kynurenine pathway and oxidative stress – implications for glioma pathobiologyNeurochemistry International, 2022
- The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's diseaseAlzheimer's & Dementia, 2021
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersJAMA, 2020
- IL-5 blocks apoptosis and tau hyperphosphorylation induced by Aβ25–35 peptide in PC12 cellsJournal of Physiology and Biochemistry, 2017
- Practical Bayesian model evaluation using leave-one-out cross-validation and WAICStatistics and Computing, 2016
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer diseaseAnnals of Clinical and Translational Neurology, 2016
- The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative diseaseJournal of Molecular Medicine, 2013
- Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease MutationsArchives of Neurology, 2012
- Blood Protein Signature for the Early Diagnosis of Alzheimer DiseaseArchives of Neurology, 2009